Clinical Trial Update: The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on the pharmacokinetics of double-boosted protease inhibitors in antiretroviral-naive HIV-1 infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 2 | Status: COMPLETED